Irbezyd- H 300/ 12.5

Main information

  • Trade name:
  • Irbezyd- H 300/ 12.5 300 mg/ 12.5 mg Tablet
  • Dosage:
  • 300 mg/ 12.5 mg
  • Pharmaceutical form:
  • Tablet
  • Units in package:
  • Opaque PVC/ PVDC- Alu foil blister pack x 10's (box of 30's); Opaque Alu/ PVC/ PVDC Foil Blister pack x 10's (box of 10's) as physi
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • Cadila Healthcare Limited

Documents

Localization

  • Available in:
  • Irbezyd- H 300/12.5 300 mg/ 12.5 mg Tablet
    Philippines
  • Language:
  • English

Status

  • Source:
  • FDA - Food And Drug Administration - Philippines
  • Authorization number:
  • DRP-7349
  • Authorization date:
  • 27-12-2022
  • Last update:
  • 09-07-2018